Clinical Trial Update: The Coherex FlatStent™ EF PFO Migraine Registry

View source ↗

Summary

The Coherex FlatStent EF PFO Migraine Registry, sponsored by Coherex Medical, studied patients with migraine and patent foramen ovale but has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Patent Foramen Ovale

Snippet

Sponsor: Coherex Medical | Conditions: Patients With Migraine and PFO | Status: TERMINATED